VEGFA and breast carcinoma: GLSO significantly decreased VEGF mRNA expression in HepG2 cells, human lung carcinoma cells (LTEP-a2), and breast carcinoma cells (MCF-7), with an approximately 50% reduction in VEGF expression in LTEP-a2 cells at 5–20 μg/mL [39,40,41].